PAS
VTYX

Point72 Asia (Singapore)’s Ventyx Biosciences VTYX Stock Holding History

Point72 Asia (Singapore)’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,096
Closed -$26.4K – 1253
2024
Q3 		$26.4K Sell
12,096
-13,207
-52% -$30.4K 0.01% 786
2024
Q2 		$58.5K Buy
+25,303
New +$105K 0.01% 612

Other funds holding VTYX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Point72 Asia (Singapore)'s VTYX Position: Q4 2024 in Review

Point72 Asia (Singapore) sold out of Ventyx Biosciences (VTYX) in Q4 2024, closing a stake of 12,096 shares — an estimated $26.4K sold.

Point72 Asia (Singapore) first reported a position in VTYX in Q2 2024 and held it in 2 quarters. The position peaked at $58.5K in Q2 2024. 124 funds tracked by Wall St. Rank hold VTYX as of Q4 2024.

  • Point72 Asia (Singapore) reported no remaining Ventyx Biosciences position as of Q4 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 12,096 Ventyx Biosciences shares in Q4 2024, an estimated $26.4K.
  • Point72 Asia (Singapore) first reported a position in Ventyx Biosciences in Q2 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Ventyx Biosciences position peaked at $58.5K in Q2 2024.
  • 124 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q4 2024, filed 14 Feb 2025.